Byrd, K. and Truong, P. 2014. Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. Kansas Journal of Medicine. 7, 4 (Nov. 2014), 167–170. DOI:https://doi.org/10.17161/kjm.v7i4.11507.